eukarys Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $717K

  • Investors
  • 2

eukarys General Information

Description

Developer of an artificial eukaryotic expression system designed to facilitate biomanufacturing yield enhancement. The company's products utilize proprietary artificial RNA polymerase technology, mRNA-based productivity boosters, and post-transcriptional modification processing to provide protein production synthesis, biologic quality preservation, and industrial scale-up, enabling pharmaceutical and biotechnology companies to increase production efficiency and manage development costs through a unified digital environment.

Contact Information

Website
www.eukarys.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Genopole Campus, 4 rue Pierre Fontaine
  • 91058 Evry
  • France
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Genopole Campus, 4 rue Pierre Fontaine
  • 91058 Evry
  • France

eukarys Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

eukarys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Nov-2026 $717K Completed Generating Revenue
1. Accelerator/Incubator 10-Jun-2025 Completed Generating Revenue
To view eukarys’s complete valuation and funding history, request access »

eukarys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view eukarys’s complete cap table history, request access »

eukarys Patents

eukarys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021322707-A1 Artificial eukaryotic expression system with enhanced performances Active 04-Aug-2020
AU-2021322707-B2 Artificial eukaryotic expression system with enhanced performances Active 04-Aug-2020
CA-3188036-A1 Artificial eukaryotic expression system with enhanced performances Pending 04-Aug-2020
EP-4192849-A1 Artificial eukaryotic expression system with enhanced performances Pending 04-Aug-2020
US-20230265479-A1 Artificial eukaryotic expression system with enhanced performances Pending 04-Aug-2020 C12N9/1247
To view eukarys’s complete patent history, request access »

eukarys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

eukarys Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Health Investment Corporation Venture Capital Minority
BioTools Innovator Accelerator/Incubator
To view eukarys’s complete investors history, request access »

eukarys FAQs

  • When was eukarys founded?

    eukarys was founded in 2010.

  • Where is eukarys headquartered?

    eukarys is headquartered in Evry, France.

  • What is the size of eukarys?

    eukarys has 4 total employees.

  • What industry is eukarys in?

    eukarys’s primary industry is Discovery Tools (Healthcare).

  • Is eukarys a private or public company?

    eukarys is a Private company.

  • What is the current valuation of eukarys?

    The current valuation of eukarys is .

  • What is eukarys’s current revenue?

    The current revenue for eukarys is .

  • How much funding has eukarys raised over time?

    eukarys has raised $717K.

  • Who are eukarys’s investors?

    Global Health Investment Corporation and BioTools Innovator have invested in eukarys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process